BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36963164)

  • 1. Decipher enzymes from human microbiota for drug discovery and development.
    Beliaeva MA; Wilmanns M; Zimmermann M
    Curr Opin Struct Biol; 2023 Jun; 80():102567. PubMed ID: 36963164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new genomic blueprint of the human gut microbiota.
    Almeida A; Mitchell AL; Boland M; Forster SC; Gloor GB; Tarkowska A; Lawley TD; Finn RD
    Nature; 2019 Apr; 568(7753):499-504. PubMed ID: 30745586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and mining of enzymes from the human gut microbiome.
    Jia B; Han X; Kim KH; Jeon CO
    Trends Biotechnol; 2022 Feb; 40(2):240-254. PubMed ID: 34304905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, functions, and diversity of the healthy human microbiome.
    Ahrodia T; Das S; Bakshi S; Das B
    Prog Mol Biol Transl Sci; 2022; 191(1):53-82. PubMed ID: 36270682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mind the Gap: Bridging the Divide from Sequencing Data to Empiric Phenotypes in the Human Gut Microbiota.
    Fansler RT; Zhu W
    mSystems; 2022 Jun; 7(3):e0020722. PubMed ID: 35695430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches.
    Dhurjad P; Dhavaliker C; Gupta K; Sonti R
    Drug Metab Dispos; 2022 Mar; 50(3):224-234. PubMed ID: 34969660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Divergence and Genomic Diversification of Gut Symbionts of Neotropical Stingless Bees.
    Sarton-Lohéac G; Nunes da Silva CG; Mazel F; Baud G; de Bakker V; Das S; El Chazli Y; Ellegaard K; Garcia-Garcera M; Glover N; Liberti J; Nacif Marçal L; Prasad A; Somerville V; ; Bonilla-Rosso G; Engel P
    mBio; 2023 Apr; 14(2):e0353822. PubMed ID: 36939321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive insights from composition to functional microbe-based biodiversity of the infant human gut microbiota.
    Lugli GA; Mancabelli L; Milani C; Fontana F; Tarracchini C; Alessandri G; van Sinderen D; Turroni F; Ventura M
    NPJ Biofilms Microbiomes; 2023 May; 9(1):25. PubMed ID: 37169786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling.
    Lau JT; Whelan FJ; Herath I; Lee CH; Collins SM; Bercik P; Surette MG
    Genome Med; 2016 Jul; 8(1):72. PubMed ID: 27363992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiome Integration in Drug Discovery and Development of Small Molecules.
    Jimonet P; Druart C; Blanquet-Diot S; Boucinha L; Kourula S; Le Vacon F; Maubant S; Rabot S; Van de Wiele T; Schuren F; Thomas V; Walther B; Zimmermann M;
    Drug Metab Dispos; 2024 Mar; 52(4):274-287. PubMed ID: 38307852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Techniques and Models for Studying the Role of the Gut Microbiota in Drug Metabolism.
    Tan J; Fu B; Zhao X; Ye L
    Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):131-147. PubMed ID: 38123834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A data-driven approach for predicting the impact of drugs on the human microbiome.
    Algavi YM; Borenstein E
    Nat Commun; 2023 Jun; 14(1):3614. PubMed ID: 37330560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity Assessment of Nano-ZnO Exposure on the Human Intestinal Microbiome, Metabolic Functions, and Resistome Using an In Vitro Colon Simulator.
    Zhang T; Zhu X; Guo J; Gu AZ; Li D; Chen J
    Environ Sci Technol; 2021 May; 55(10):6884-6896. PubMed ID: 33969685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycan degradation (GlyDeR) analysis predicts mammalian gut microbiota abundance and host diet-specific adaptations.
    Eilam O; Zarecki R; Oberhardt M; Ursell LK; Kupiec M; Knight R; Gophna U; Ruppin E
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle alters GUT-bacteria function: Linking immune response and host.
    Jazayeri O; Daghighi SM; Rezaee F
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):625-635. PubMed ID: 29566905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese Cats.
    Ma X; Brinker E; Graff EC; Cao W; Gross AL; Johnson AK; Zhang C; Martin DR; Wang X
    Microbiol Spectr; 2022 Jun; 10(3):e0083722. PubMed ID: 35467389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and the microbiome: pitfalls and potential.
    Lin H; He QY; Shi L; Sleeman M; Baker MS; Nice EC
    Expert Rev Proteomics; 2019 Jun; 16(6):501-511. PubMed ID: 30223687
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbiome systems biology advancements for natural well-being.
    Chatterjee G; Negi S; Basu S; Faintuch J; O'Donovan A; Shukla P
    Sci Total Environ; 2022 Sep; 838(Pt 2):155915. PubMed ID: 35568180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.